Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

BNTXBNTX
Showing 8 of 24 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in BIONTECH SE

CITADEL ADVISORS LLC holds 951,372 shares of BNTX (BIONTECH SE), worth $84.6M as of 2026-Q1. The position was increased (+40.3% shares). BNTX represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$84.6M

Current Shares

951,372

Total Value Change

+$79.2M

Total Shares Change

+885,160

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
951,372
+40.3%
$84.6M0.0%$100.76
40
2025-Q4
Increased
678,175
+74.1%
$64.6M0.0%$95.28
44
2025-Q3
Increased
389,495
+143x
$38.4M0.0%$98.10
47
2025-Q2
Decreased
2,712
-98.8%
$288,7470.0%$106.72
0
2025-Q1
Increased
221,190
+73.6%
$20.1M0.0%$94.95
43
2024-Q4
Increased
127,431
+227.6%
$14.5M0.0%$112.58
45
2024-Q3
Decreased
38,904
-41.2%
$4.6M0.0%$118.22
0
2024-Q2
Decreased
66,212
-86.2%
$5.3M0.0%$80.36
0

Other major holders of BNTX: BAILLIE GIFFORD & CO, PRIMECAP MANAGEMENT CO/CA/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used